AMBA vs MCHP vs CEVA

For growth investors, Ambarella, Inc.

(AMBA) is the stronger pick with 25. 8% revenue growth year-over-year, versus -42. 3% for Microchip Technology Incorporated (MCHP). Analysts rate Ambarella, Inc. (AMBA) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Microchip Technology Incorporated (MCHP) delivered a total return of +50.

8%, compared to -32. 5% for CEVA, Inc. (CEVA). Over 10 years, the gap is even starker: MCHP returned +375. 9% versus CEVA's +32. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Microchip Technology Incorporated (MCHP) is the lower-risk stock at 1.

70β versus CEVA, Inc. 's 2. 76β — meaning CEVA is approximately 63% more volatile than MCHP relative to the S&P 500. On balance sheet safety, Ambarella, Inc. (AMBA) carries a lower debt/equity ratio of 1% versus 80% for Microchip Technology Incorporated — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Ambarella, Inc.

(AMBA) is pulling ahead at 25. 8% versus -42. 3% for Microchip Technology Incorporated (MCHP). On earnings-per-share growth, the picture is similar: Ambarella, Inc. grew EPS 33. 2% year-over-year, compared to -100. 1% for Microchip Technology Incorporated. Over a 3-year CAGR, CEVA leads at -2. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Microchip Technology Incorporated (MCHP) is the more profitable company, earning -0.

0% net margin versus -41. 1% for Ambarella, Inc. — meaning it keeps -0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MCHP leads at 6. 7% versus -44. 4% for AMBA. At the gross margin level — before operating expenses — CEVA leads at 88. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Microchip Technology Incorporated (MCHP) trades at 65.

7x forward P/E versus 96. 9x for Ambarella, Inc. — 31. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMBA: 30. 3% to $98. 33.

In this comparison, MCHP (1.

8% yield) pays a dividend. AMBA, CEVA do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Microchip Technology Incorporated (MCHP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1.

8% yield, +375. 9% 10Y return). CEVA, Inc. (CEVA) carries a higher beta of 2. 76 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MCHP: +375. 9%, CEVA: +32. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AMBA is a small-cap high-growth stock; MCHP is a mid-cap quality compounder stock; CEVA is a small-cap quality compounder stock. MCHP pays a dividend while AMBA, CEVA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.